
Tejash Vijay Shah
About Tejash Vijay Shah
Data last updated:
Tejash Vijay Shah is a Director at Bdr Pharmaceuticals International Private Limited (since 2008), Director at Bdr Lifesciences Private Limited (since 2021) and Director at Magnum Chemi-Gran Private Limited (since 2014), and holds 2 more current directorships. The companies operate in Pharma, Life Sciences and Real Estate and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹1,347 Cr; the largest is Bdr Pharmaceuticals International Private Limited at ₹1,137 Cr (FY 2025). Earlier, Tejash Vijay Shah was a Director at Cibeles Pharmaceuticals Private Limited (2019–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jan 2008 | 2002 | ₹1,137 Cr (FY 2025) | Active | |
| Director | 19 Apr 2021 | 1993 | ₹177 Cr (FY 2025) | Active | |
| Director | 12 Aug 2014 | 2005 | ₹29.74 Cr (FY 2025) | Active | |
| Director | 21 Aug 2023 | 2020 | ₹3.24 Cr (FY 2024) | Active | |
| Designated Partner | 20 Aug 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Oct 2019 | 2019 | ₹27.15 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Tejash Vijay Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejash Vijay Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejash Vijay Shah
Tejash Vijay Shah currently holds 5 directorships: Bdr Pharmaceuticals International Private Limited (Director, since 16 Jan 2008, revenue ₹1,137 Cr (FY 2025)); Bdr Lifesciences Private Limited (Director, since 19 Apr 2021, revenue ₹177 Cr (FY 2025)); Magnum Chemi-Gran Private Limited (Director, since 12 Aug 2014, revenue ₹29.74 Cr (FY 2025)); Nutrigene Biosciences Private Limited (Director, since 21 Aug 2023, revenue ₹3.24 Cr (FY 2024)); Majorelle Llp (Designated Partner, since 20 Aug 2020).
Tejash Vijay Shah was first appointed on 16 Jan 2008 as Director at Bdr Pharmaceuticals International Private Limited. The most recent appointment on record is 21 Aug 2023 at Nutrigene Biosciences Private Limited.
The 4 current companies of Tejash Vijay Shah that report revenue have a combined latest revenue of ₹1,347 Cr: Bdr Pharmaceuticals International Private Limited ₹1,137 Cr (FY 2025); Bdr Lifesciences Private Limited ₹177 Cr (FY 2025); Magnum Chemi-Gran Private Limited ₹29.74 Cr (FY 2025); Nutrigene Biosciences Private Limited ₹3.24 Cr (FY 2024).
Tejash Vijay Shah held 1 earlier board appointment: Cibeles Pharmaceuticals Private Limited (Director, 22 Oct 2019 to 20 Feb 2020).
The current boards of Tejash Vijay Shah's companies include Anand Kailash Bagaria (Bdr Pharmaceuticals International Private Limited), Aravind Manappa Badiger (Bdr Pharmaceuticals International Private Limited), Dharmesh Mahendra Shah (Bdr Pharmaceuticals International Private Limited), Jayesh Shantilal Trivedi (Bdr Pharmaceuticals International Private Limited), Manish Gaur (Bdr Pharmaceuticals International Private Limited), Nilam Maulik Vyas (Bdr Pharmaceuticals International Private Limited), among others.